Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Gains from Investment Securities (2023 - 2025)

Profound Medical (PROF) has 3 years of Gains from Investment Securities data on record, last reported at $92900.0 in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 90.19% year-over-year to $92900.0; the TTM value through Dec 2025 reached $92900.0, down 90.19%, while the annual FY2025 figure was $92900.0, 90.19% down from the prior year.
  • Gains from Investment Securities reached $92900.0 in Q4 2025 per PROF's latest filing, down from $197684.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.5 million in Q4 2023 and bottomed at $14000.0 in Q1 2024.
  • Average Gains from Investment Securities over 3 years is $388951.1, with a median of $173658.0 recorded in 2024.
  • The widest YoY moves for Gains from Investment Securities: up 1237.97% in 2025, down 90.19% in 2025.
  • A 3-year view of Gains from Investment Securities shows it stood at $1.5 million in 2023, then crashed by 35.8% to $946900.0 in 2024, then crashed by 90.19% to $92900.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $92900.0 in Q4 2025, $197684.0 in Q2 2025, and $187316.0 in Q1 2025.